Effect of high LH/FSH ratio on women with polycystic ovary syndrome undergoing in vitro maturation treatment

Journal of Reproductive Medicine

Volumn 58, Issue 5-6, 2013, Pages 219-223

  Wiser, Amir ^a   Shehata, Fady ^a   Holzer, Hananel ^a   Hyman, Jordana H ^a   Shalom Paz, Einat ^a   Son, Weon Young ^a   Tulandi, Togas ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Follicle stimulating hormone; In vitro maturation of oocytes; Luteinizing hormone; Ovulation induction; Polycystic ovary syndrome

Indexed keywords

CHORIONIC GONADOTROPIN; CLOMIFENE CITRATE; ESTRADIOL; FOLLITROPIN; GONADOTROPIN; LUTEINIZING HORMONE; PROGESTERONE; TESTOSTERONE;

ADULT; ANTRAL FOLLICLE COUNT; ARTICLE; ESTRADIOL BLOOD LEVEL; FEMALE; FEMALE GENITAL TRACT PARAMETERS; HUMAN; IN VITRO OOCYTE MATURATION; OOCYTE; OOCYTE MATURATION; OOCYTE RETRIEVAL; OVARY FOLLICLE DEVELOPMENT; OVARY POLYCYSTIC DISEASE; PREGNANCY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TESTOSTERONE BLOOD LEVEL;

ADULT; CELLS, CULTURED; ENDOMETRIUM; ESTRADIOL; FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; HUMANS; LUTEINIZING HORMONE; OOCYTES; OVARIAN FOLLICLE; POLYCYSTIC OVARY SYNDROME; PREGNANCY; TESTOSTERONE;

EID: 84877972083     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Azziz R, Woods KS, Reyna R, et al: The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 2004;89:2745-2749
2. March WA, Moore VM, Willson KJ, et al: The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod 2010;25: 544-551
3. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group: Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19-25
4. McCartney CR, Eagleson CA, Marshall JC: Regulation of gonadotropin secretion: Implications for polycystic ovary syndrome. Semin Reprod Med 2002;20:317-326
5. Tarlatzis BC, Grimbizis G, Pournaropoulos F, et al: The prognostic value of basal luteinizing hormone: Folliclestimulating hormone ratio in the treatment of patients with polycystic ovarian syndrome by assisted reproduction techniques. Hum Reprod 1995;10:2545-2549
6. Gordon UD, Harrison RF, Fawzy M, et al: A randomized prospective assessor-blind evaluation of luteinizing hormone dosage and in vitro fertilization outcome. Fertil Steril 2001;75:324-331
7. Mendoza C, Ruiz-Requena E, Ortega E, et al: Follicular fluid markers of oocyte developmental potential. Hum Reprod 2002;17:1017-1022
8. Piquette GN: The in vitro maturation (IVM) of human oocytes for in vitro fertilization (IVF): Is it time yet to switch to IVM-IVF? Fertil Steril 2006;85:833-835; discussion 41
9. Shrim A, Elizur SE, Seidman DS, et al: Elevated day 3 FSH/LH ratio due to low LH concentrations predicts reduced ovarian response. Reprod Biomed Online 2006;12:418-422
10. Son WY, Tan SL: Laboratory and embryological aspects of hCG-primed in vitro maturation cycles for patients with polycystic ovaries. Hum Reprod Update 2010;16:675-689
11. Brodin T, Bergh T, Berglund L, et al: High basal LH levels in combination with low basal FSH levels are associated with high success rates at assisted reproduction. Hum Reprod 2009;24:2755-2759
12. van der Spuy ZM, Dyer SJ: The pathogenesis of infertility and early pregnancy loss in polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol 2004;18:755-771
13. Grody MH, Lampe EH, Masters WH: Estrogen-androgen substitution therapy in the aged female. I. Uterine bioassay report. Obstet Gynecol 1953;2:36-45
14. Rose GL, Dowsett M, Mudge JE, et al: The inhibitory effects of danazol, danazol metabolites, gestrinone, and testosterone on the growth of human endometrial cells in vitro. Fertil Steril 1988;49:224-228
15. Okon MA, Laird SM, Tuckerman EM, et al: Serum androgen levels in women who have recurrent miscarriages and their correlation with markers of endometrial function. Fertil Steril 1998;69:682-690
16. Ng EH, Chan CC, Ho PC: Are there differences in ultrasound parameters between Chinese women with polycystic ovaries only and with polycystic ovary syndrome? Eur J Obstet Gynecol Reprod Biol 2006;125:92-98
17. Taylor AE, McCourt B, Martin KA, et al: Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome. J Clin Endocrinol Metab 1997;82:2248-2256